Acetylcysteine to prevent angiography-related renal tissue injury (The APART Trial)

Radiographic contrast agent-induced nephropathy has been largely studied, and its risk factors, pathophysiology, and prophylaxis have been determined. Contrast agents cause acute renal failure, increase in-hospital morbidity, mortality, and cost of medical care, prolong hospitalizations, and lead to...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 2002-02, Vol.89 (3), p.356
Main Authors: Diaz-Sandoval, Larry J, Kosowsky, Bernard D, Losordo, Douglas W
Format: Article
Language:English
Subjects:
Cardiovascular disease
Catheters
Injuries
Kidneys
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 3
container_start_page 356
container_title The American journal of cardiology
container_volume 89
creator Diaz-Sandoval, Larry J
Kosowsky, Bernard D
Losordo, Douglas W
description Radiographic contrast agent-induced nephropathy has been largely studied, and its risk factors, pathophysiology, and prophylaxis have been determined. Contrast agents cause acute renal failure, increase in-hospital morbidity, mortality, and cost of medical care, prolong hospitalizations, and lead to chronic renal failure.
doi_str_mv 10.1016/S0002-9149(01)02243-3
format article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_230374109</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>105260703</sourcerecordid><originalsourceid>FETCH-LOGICAL-p112t-9d776645ebb32a61020c999b600042aa24981ce638ac964edbe7fc967e776a693</originalsourceid><addsrcrecordid>eNo9jk1LxDAYhIMoWFd_ghA87R6ieZNs0hzL4hcsKG49L2n77m5LaWuSCv33FhRPMwMzw0PILfB74KAfdpxzwSwou-Sw4kIoyeQZSSA1loEFeU6S_8oluQqhmSPAWidkl5UYp7acQsS6Qxp7Onj8xi5S1x3r_ujdcJqYx9ZFrKjHzrU01iGMSOuuGf1El_kJafaefeQ097VrV9fk4uDagDd_uiCfT4_55oVt355fN9mWDQAiMlsZo7VaY1FI4TRwwUtrbaFnOCWcE8qmUKKWqSutVlgVaA6zMzjvnLZyQe5-fwfff40Y4r7pRz8Dhr2QXBoF3MofKUlR8Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>230374109</pqid></control><display><type>article</type><title>Acetylcysteine to prevent angiography-related renal tissue injury (The APART Trial)</title><source>ScienceDirect Journals</source><creator>Diaz-Sandoval, Larry J ; Kosowsky, Bernard D ; Losordo, Douglas W</creator><creatorcontrib>Diaz-Sandoval, Larry J ; Kosowsky, Bernard D ; Losordo, Douglas W</creatorcontrib><description>Radiographic contrast agent-induced nephropathy has been largely studied, and its risk factors, pathophysiology, and prophylaxis have been determined. Contrast agents cause acute renal failure, increase in-hospital morbidity, mortality, and cost of medical care, prolong hospitalizations, and lead to chronic renal failure.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/S0002-9149(01)02243-3</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>New York: Elsevier Limited</publisher><subject>Cardiovascular disease ; Catheters ; Injuries ; Kidneys</subject><ispartof>The American journal of cardiology, 2002-02, Vol.89 (3), p.356</ispartof><rights>Copyright Elsevier Sequoia S.A. Feb 1, 2002</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Diaz-Sandoval, Larry J</creatorcontrib><creatorcontrib>Kosowsky, Bernard D</creatorcontrib><creatorcontrib>Losordo, Douglas W</creatorcontrib><title>Acetylcysteine to prevent angiography-related renal tissue injury (The APART Trial)</title><title>The American journal of cardiology</title><description>Radiographic contrast agent-induced nephropathy has been largely studied, and its risk factors, pathophysiology, and prophylaxis have been determined. Contrast agents cause acute renal failure, increase in-hospital morbidity, mortality, and cost of medical care, prolong hospitalizations, and lead to chronic renal failure.</description><subject>Cardiovascular disease</subject><subject>Catheters</subject><subject>Injuries</subject><subject>Kidneys</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNo9jk1LxDAYhIMoWFd_ghA87R6ieZNs0hzL4hcsKG49L2n77m5LaWuSCv33FhRPMwMzw0PILfB74KAfdpxzwSwou-Sw4kIoyeQZSSA1loEFeU6S_8oluQqhmSPAWidkl5UYp7acQsS6Qxp7Onj8xi5S1x3r_ujdcJqYx9ZFrKjHzrU01iGMSOuuGf1El_kJafaefeQ097VrV9fk4uDagDd_uiCfT4_55oVt355fN9mWDQAiMlsZo7VaY1FI4TRwwUtrbaFnOCWcE8qmUKKWqSutVlgVaA6zMzjvnLZyQe5-fwfff40Y4r7pRz8Dhr2QXBoF3MofKUlR8Q</recordid><startdate>20020201</startdate><enddate>20020201</enddate><creator>Diaz-Sandoval, Larry J</creator><creator>Kosowsky, Bernard D</creator><creator>Losordo, Douglas W</creator><general>Elsevier Limited</general><scope>7TS</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P64</scope></search><sort><creationdate>20020201</creationdate><title>Acetylcysteine to prevent angiography-related renal tissue injury (The APART Trial)</title><author>Diaz-Sandoval, Larry J ; Kosowsky, Bernard D ; Losordo, Douglas W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p112t-9d776645ebb32a61020c999b600042aa24981ce638ac964edbe7fc967e776a693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Cardiovascular disease</topic><topic>Catheters</topic><topic>Injuries</topic><topic>Kidneys</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Diaz-Sandoval, Larry J</creatorcontrib><creatorcontrib>Kosowsky, Bernard D</creatorcontrib><creatorcontrib>Losordo, Douglas W</creatorcontrib><collection>Physical Education Index</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Diaz-Sandoval, Larry J</au><au>Kosowsky, Bernard D</au><au>Losordo, Douglas W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acetylcysteine to prevent angiography-related renal tissue injury (The APART Trial)</atitle><jtitle>The American journal of cardiology</jtitle><date>2002-02-01</date><risdate>2002</risdate><volume>89</volume><issue>3</issue><spage>356</spage><pages>356-</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>Radiographic contrast agent-induced nephropathy has been largely studied, and its risk factors, pathophysiology, and prophylaxis have been determined. Contrast agents cause acute renal failure, increase in-hospital morbidity, mortality, and cost of medical care, prolong hospitalizations, and lead to chronic renal failure.</abstract><cop>New York</cop><pub>Elsevier Limited</pub><doi>10.1016/S0002-9149(01)02243-3</doi></addata></record>
fulltext fulltext
identifier ISSN: 0002-9149
ispartof The American journal of cardiology, 2002-02, Vol.89 (3), p.356
issn 0002-9149
1879-1913
language eng
recordid cdi_proquest_journals_230374109
source ScienceDirect Journals
subjects Cardiovascular disease
Catheters
Injuries
Kidneys
title Acetylcysteine to prevent angiography-related renal tissue injury (The APART Trial)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T13%3A53%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acetylcysteine%20to%20prevent%20angiography-related%20renal%20tissue%20injury%20(The%20APART%20Trial)&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Diaz-Sandoval,%20Larry%20J&rft.date=2002-02-01&rft.volume=89&rft.issue=3&rft.spage=356&rft.pages=356-&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/S0002-9149(01)02243-3&rft_dat=%3Cproquest%3E105260703%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p112t-9d776645ebb32a61020c999b600042aa24981ce638ac964edbe7fc967e776a693%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=230374109&rft_id=info:pmid/&rfr_iscdi=true